The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye Complications

▴ Eye Complications Post-Miltefosine Treatment
Numerous cases of eye complications post-miltefosine treatment have emerged, shedding light on the severity of this issue

In recent years, India has made significant waves in combating Kala-azar, a parasitic disease, achieving the elimination target in 2024. However, a concerning revelation has emerged regarding the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) using the drug Miltefosine. This treatment, while effective against PKDL, has been associated with severe eye problems, including blindness, prompting urgent attention and further investigation.

Understanding Kala-azar and its Skin Manifestation: Kala-azar, scientifically known as Visceral Leishmaniasis, is a neglected tropical disease caused by the parasite Leishmania donovani, transmitted through the bite of female sand flies. With symptoms such as fever, weight loss, anemia, and enlarged spleen and liver, If left untreated, Kala-azar can be fatal. Post-Kala-azar Dermal Leishmaniasis (PKDL) is a skin manifestation of Kala-azar, affecting about 5-10% of treated patients. Though seemingly harmless, PKDL harbours the parasite, posing a risk of disease transmission within the community.

The Miltefosine Saga: Miltefosine, originally an anticancer drug, is the primary treatment for PKDL. However, recent studies have raised concerns about its association with adverse ocular events, including corneal damage and blindness. The World Health Organization (WHO) and Indian government have acknowledged this issue, prompting the formulation of guidelines for healthcare providers.

Unveiling Eye Complications: Numerous cases of eye complications post-miltefosine treatment have emerged, shedding light on the severity of this issue. Patients have reported symptoms such as eye pain, inflammation, and photophobia, ultimately leading to vision loss. Despite efforts to address these complications, access to timely and appropriate eye care remains a challenge, particularly for rural and marginalized communities.

The Role of Medical Professionals: Ophthalmologists and clinicians have been at the forefront of diagnosing and managing these eye complications. Through diligent observation and treatment, they strive to mitigate the impact of miltefosine-induced ocular damage. However, the success of interventions such as corneal implants hinges on factors such as early detection and follow-up care.

Challenges and Solutions: Limited awareness among healthcare providers and patients, coupled with logistical constraints, pose significant challenges in addressing this issue effectively. Collaborative efforts are needed to enhance awareness, facilitate timely eye examinations, and provide access to specialized care for affected individuals.

Towards a Safer Future: While the road ahead may be fraught with challenges, ongoing research and collaborative initiatives offer hope for reducing the adverse effects of miltefosine treatment. By prioritizing patient safety and leveraging multidisciplinary expertise, we can strive towards safer and more effective treatment strategies for Kala-azar and its complications.

Note: This article draws inspiration from the findings presented in the report by

Tags : #

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024